Keywords: b-ms, completes, submission, dasatinib, nda, drug, major

B-MS completes submission of dasatinib NDA

Article | 09 January 2006

Print This

US drug major Bristol-Myers Squibb has completed the rolling submission of its New Drug Application to the Food and Drug ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in